Table 3 Multivariate analysis for DFS and OS of diabetic NSCLC patients
From: Prognostic value of metformin for non-small cell lung cancer patients with diabetes
DFS | OS | |||||
|---|---|---|---|---|---|---|
p value | HR | 95% CI | p value | HR | 95% CI | |
Stage | 0.022 | 1.758 | 1.157–2.304 | 0.008 | 1.510 | 1.224–1.987 |
I | ||||||
II | ||||||
III | ||||||
Tumor recurrence | – | – | – | 0.017 | 1.700 | 1.311–2.247 |
No | ||||||
Yes | ||||||
Metformin use | 0.011 | 0.687 | 0.414–0.903 | 0.035 | 0.588 | 0.466–0.895 |
No | ||||||
Yes | ||||||